SECTOR : Healthcare
ENTRY DATE : 2020
BUSINESS : Co-investment
WEB : www.lgcgroup.com/
Provider of critical components across the clinical diagnostics, pharmaceutical and research markets
LCG offers a full range of genomic analysis tools (reagents for DNA reactions), measurement tools (reference materials, laboratory testing) and supply chain quality insurance solutions. Its Genomics activity, that produces and distributes reagents and instruments for DNA reactions intended for pharmaceutical and industrial groups, notably produces the materials required to manufacture Covid-19 tests.